MaaT Pharma: Funding, Investors & Team (Sep 2026)
MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating a range of cancers and Graft-versus-Host-Disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into improving outcomes of immunotherapy in solid tumors, we have built a powerful discovery and analysis platform, GutPrint®, to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions.
MaaT Pharma has raised $66.0M across 3 funding rounds on record, the most recent an undisclosed round of $44.1M announced in Jul 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MaaT Pharma Company Profile and Key Stats
Latest funding round on record: Jul 2025.
MaaT Pharma Funding Rounds
MaaT Pharma raised $2.2M in a Grant announced in Jul 2021.
2.8 years later, an undisclosed round of $19.7M was announced in May 2024.
1.2 years later, an undisclosed round of $44.1M was announced in Jul 2025.
MaaT Pharma Founders and Leadership Team
No contact details are on record for this team yet.
MaaT Pharma Funding Compared to Other Biotechnology Startups
MaaT Pharma's latest round of $44.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MaaT Pharma in Biotechnology and Lyon
Companies Similar to MaaT Pharma
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
MaaT Pharma Funding FAQs
What does MaaT Pharma do?
MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating a range of cancers and Graft-versus-Host-Disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into improving outcomes of immunotherapy in solid tumors, we have built a powerful discovery and analysis platform, GutPrint®, to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions.
How much funding has MaaT Pharma raised?
MaaT Pharma has raised $66.0M across 3 rounds on record. The most recent is an undisclosed round of $44.1M announced in Jul 2025.
When did MaaT Pharma last raise funding?
MaaT Pharma's most recent funding round on record is an undisclosed round of $44.1M, announced in Jul 2025.
Who founded MaaT Pharma?
FundedIQ lists Herve Affagard (Founder) at MaaT Pharma.
Where is MaaT Pharma headquartered?
MaaT Pharma is based in Lyon, Rhone-Alpes, France.
How many employees does MaaT Pharma have?
MaaT Pharma is in the 11-50 employee band.
How does MaaT Pharma's funding compare to other Biotechnology startups?
MaaT Pharma's latest round of $44.1M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's MaaT Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MaaT Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.